Cargando…
Apixaban Prophylactic Anticoagulation in Patients with Nephrotic Syndrome
Background Nephrotic syndrome (NS) is associated with an increased risk of thromboembolic events (TEs), due to hemostatic derangements. The use of direct oral anticoagulants (DOACs) in the prevention of TE has not been studied intensively in patients suffering from NS. Methods The method included...
Autores principales: | Van Meerhaeghe, Tess, Cez, Alexandre, Dahan, Karine, Esteve, Emmanuel, Elalamy, Ismail, Boffa, Jean Jacques, Ponlot, Eleonore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546608/ https://www.ncbi.nlm.nih.gov/pubmed/36299618 http://dx.doi.org/10.1055/a-1920-6224 |
Ejemplares similares
-
Serum Albumin Still of Interest to Predict Outcomes in Membranous Nephropathy in the Era of Phospholipase A2 Receptor
por: Delafosse, Marion, et al.
Publicado: (2020) -
Prophylactic Anticoagulation in Nephrotic Syndrome
por: Gerstein, Jonathon, et al.
Publicado: (2023) -
Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications
por: Kelddal, Sarah, et al.
Publicado: (2019) -
A Systematic Review of Prophylactic Anticoagulation in Nephrotic Syndrome
por: Lin, Raymond, et al.
Publicado: (2019) -
Retroperitoneal Bleeding: An Experience During Prophylactic Anticoagulation in a Patient With Nephrotic Syndrome
por: Okada, Mari, et al.
Publicado: (2017)